Aligos Therapeutics, Inc. (ALGS) vs DocGo Inc. (DCGO)

A side-by-side comparison of Aligos Therapeutics, Inc. and DocGo Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ALGS vs DCGO

growth of $100 · dividends reinvested · last 6y
ALGS -99.1% (-54.4%/yr)DCGO -96.5% (-42.7%/yr)DCGO compounded faster over this window
050100150Start $100202120222023202420252026$1$4
ALGS DCGO

ALGS vs DCGO: by the numbers

  • •DCGO is the larger company ($36M vs $33M market cap).
  • •Both run net losses; DCGO's is the smaller (-65.29% vs -241.01% net margin).
  • •DCGO grew revenue faster over the past five years (11.63% vs -15.85% CAGR).

Metrics side by side

Valuation

MetricALGSDCGO
P/S ratio1.050.12
P/B ratio1.040.30

Profitability

MetricALGSDCGO
Gross margin57.46%30.12%
Operating margin-4024.93%-27.67%
Net margin-241.01%-65.29%
ROE-238.24%-161.63%
ROIC-207.97%-89.44%

Growth (annualized)

MetricALGSDCGO
Revenue CAGR (5Y)-15.85%11.63%
Total return CAGR (5Y)-57.15%-48.40%

Frequently asked

Which has grown faster, ALGS or DCGO?
Over the past five years, DCGO grew revenue faster — ALGS at a -15.85% CAGR versus DCGO at 11.63%.
How have ALGS and DCGO total returns compared?
Over the past 5 years, ALGS delivered -57.15% and DCGO delivered -48.40% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.